NSE ScannerOpen the scanner

Pharmaceuticals · Pharmaceuticals: Major · NSE: KPL · data 2026-10-30

Kwality Pharmaceuticals Ltd

₹3,475.3-5.58% on 30 OctHealth: Strong 8.5/10
Apr 2026Low ₹1,579.55 · High ₹3,844.9+109.0%

In plain words

Price: 12.0% below its 52-week high of ₹3,949.

Delivery: 43.1% of traded shares were kept for delivery over the last 10 sessions, against 43.1% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹3,475.3
Market cap
₹3,819 cr
P/E
44.5
P/B
—
ROE
22.6%
ROCE
31.4%
Debt / equity
0.39
Dividend yield
0.00%
1-year return
98.9%
52-week high
₹3,949
52-week low
₹1,561
Operating margin
20.8%

Growth

Revenue (last 12 months)₹554 cr
Net profit (last 12 months)₹81 cr
Sales growth, 3 years (yearly)26.1%
Profit growth, 3 years (yearly)51.5%

Smart-money activity

15/100 · Weak over the last ~60 sessions, data 2026-10-30

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Kwality Pharmaceuticals Ltd debt-free?

Its latest reported debt-to-equity ratio is 0.39.

What is Kwality Pharmaceuticals Ltd's P/E ratio?

About 44.5, based on the last 12 months' earnings and a price of ₹3,475.3 (data 2026-10-30).

What is the 52-week high and low of Kwality Pharmaceuticals Ltd?

The 52-week high is ₹3,949 and the 52-week low is ₹1,561.

Similar companies

Gufic Biosciences Limited (GUFICBIO) · Aarti Drugs Limited (AARTIDRUGS) · Zota Health Care Ltd. (ZOTA) · Ind-Swift Laboratories Ltd. (INDSWFTLAB) · Unichem Laboratories Limited (UNICHEMLAB)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open KPL in NSE Scanner →
Share on WhatsAppShare on Telegram